5/7/2023 0 Comments Iconquer hike![]() ![]() IConquer MS teams up with the National MS Society and Quest Diagnostics for a study that will track the long-term effects of COVID-19 vaccines on b-cells and T-cells among people on anti-cd20 medications 5:14Ī research team at Oregon Science & Health University are exploring a unique pathway to remyelination, with promising early results 7:41Ī study shows that the rate of MS in different countries may have less to do with latitude and more to do with healthcare spending 11:57īurgers to Beat MS beats its goal and raises $1.8 million dollars 15:06ĭr. The Hispanic/Latinx MS Experience Summit takes place on Sept 15. You can catch the replay of the MS Society's webcast or read the one-page "explainer" about how and when the new drug pricing law will impact your MS medications if you're on Medicare 2:47 This Week: How shared decision-making shapes your MS treatment plan :22 We have a lot to talk about! Are you ready for RealTalk MS?! We'll share study results that indicate the rate of MS in a country may have less to do with latitude and sun exposure and more to do with healthcare spending.Īnd we're giving a shout-out to A&W Canada and the MS Society of Canada for raising $1.8 million during the Burgers to Beat MS event. We'll share study results that point to a novel pathway to myelin repair. We'll tell you about a new research collaboration between iConquer MS, the National MS Society, and Quest Diagnostics We'll share the registration details for next week's Hispanic/Latinx MS Experience Summit We'll also tell you where you can catch the video replay of an MS Society webcast that explains how and when the new drug pricing law will impact the cost of your MS medications if you're on Medicare. Marijean Buhse joins me to walk us through how shared decision-making works for people living with MS - and what to do if it isn't working for you. And some patients worry that shared decision-making means they have more work to do in preparing for an appointment with their healthcare provider.ĭr. Shared decision-making offers the patient an opportunity to discuss their treatment goals, explain their risk tolerance, and talk about their comfort level with side effects.īut not every neurologist, nurse practitioner, or MS specialist has made the transition to shared decision-making. The conversation between a doctor and patient is evolving from a time when that conversation was often limited to the doctor prescribing a particular disease-modifying medication and the patient silently nodding their head in agreement to something much more closely resembling a real conversation.
0 Comments
Leave a Reply. |